CNS:NYE-Cohen & Steers Inc (USD)

COMMON STOCK | Asset Management |

Last Closing

USD 95.06

Change

-0.53 (-0.55)%

Market Cap

N/A

Volume

0.30M

Analyst Target

USD 72.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Asset Management

Symbol Name Price(Change) Market Cap
BX Blackstone Group Inc

+0.70 (+0.46%)

USD 192.43B
BLK BlackRock Inc

+8.22 (+0.88%)

USD 138.77B
KKR KKR & Co LP

-0.29 (-0.22%)

USD 122.06B
BN Brookfield Corp

+1.15 (+2.20%)

USD 79.16B
APO Apollo Global Management LLC C..

+0.97 (+0.78%)

USD 70.92B
ARES Ares Management LP

-2.00 (-1.27%)

USD 49.47B
AMP Ameriprise Financial Inc

+4.42 (+0.95%)

USD 45.47B
OWL Blue Owl Capital Inc

-0.28 (-1.46%)

USD 26.59B
RJF Raymond James Financial Inc.

-2.58 (-2.06%)

USD 25.60B
BAM Brookfield Asset Management In..

+0.03 (+0.06%)

USD 19.81B

ETFs Containing CNS

MPXG:LSE Amundi Index MSCI Pacific.. 5.29 % 0.00 %

+43.25 (+0.62%)

N/A
CP9:PA Amundi Index MSCI Pacific.. 4.61 % 0.00 %

+8.10 (+0.62%)

USD 0.32B
18MM:F Amundi Funds - Amundi Ind.. 4.61 % 0.00 %

+11.40 (+0.62%)

N/A
18MM:XETRA Amundi Index MSCI Pacific.. 4.61 % 0.00 %

+13.50 (+0.62%)

USD 0.32B
CP9U:PA Amundi MSCI Pacific ex Ja.. 4.61 % 0.00 %

+9.20 (+0.62%)

USD 0.03B
APXJ:XETRA Amundi Index MSCI Pacific.. 4.61 % 0.00 %

+0.14 (+0.62%)

USD 0.64B
CYBG:LSE VanEck Bionic Engineering.. 4.25 % 0.00 %

-0.13 (0.62%)

N/A
CIB0:XETRA VanEck Bionic Engineering.. 4.15 % 0.00 %

+0.02 (+0.62%)

USD 6.28M
FAIR:AU BetaShares Australian Sus.. 4.06 % 0.00 %

+0.07 (+0.62%)

USD 1.50B
MTUM:AU Betashares Australian Mom.. 3.30 % 0.00 %

+0.16 (+0.62%)

N/A
BATF:XETRA L&G Asia Pacific ex Japan.. 2.71 % 0.00 %

+0.24 (+0.62%)

N/A
OZXX:AU Global X Australia Ex Fin.. 2.58 % 0.00 %

+0.14 (+0.62%)

N/A
DGRS WisdomTree U.S. SmallCap .. 2.28 % 0.38 %

+0.35 (+0.62%)

USD 0.41B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.24 % 0.00 %

+0.09 (+0.62%)

N/A
EX20:AU BetaShares Australian Ex-.. 2.20 % 0.00 %

+0.32 (+0.62%)

USD 0.27B
DES WisdomTree U.S. SmallCap .. 0.00 % 0.38 %

+0.08 (+0.62%)

USD 2.05B
WELP:LSE HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

-6.80 (0.62%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Asset Management) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.52% 94% A 87% B+
Dividend Return 2.34% 10% F 48% F
Total Return 27.86% 91% A- 87% B+
Trailing 12 Months  
Capital Gain 53.13% 99% N/A 91% A-
Dividend Return 3.77% 11% F 53% F
Total Return 56.89% 99% N/A 92% A
Trailing 5 Years  
Capital Gain 72.80% 96% N/A 78% C+
Dividend Return 26.85% 42% F 81% B-
Total Return 99.65% 95% A 83% B
Average Annual (5 Year Horizon)  
Capital Gain 6.14% 84% B 59% D-
Dividend Return 10.14% 78% C+ 63% D
Total Return 4.01% 26% F 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 24.75% 24% F 42% F
Risk Adjusted Return 40.98% 68% D+ 58% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector